Francesco Patti

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder

Takashi Yamamura, Ingo Kleiter, Kazuo Fujihara et al. · New England Journal of Medicine · 2019 · 642 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

Maria Pia Sormani, Nicola De Rossi, Irene Schiavetti et al. · Annals of Neurology · 2021 · 461 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

The Rao’s Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population

Maria Pia Amato, Emilio Portaccio, Benedetta Goretti et al. · Multiple Sclerosis Journal · 2006 · 402 citations

Social Sciences, Neurology, Psychology +17

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis

Virginia Devonshire, Yves Lapierre, R. Macdonell et al. · European Journal of Neurology · 2010 · 340 citations

Pharmacy, Neurology, Pharmacotherapy +12